Economic and clinical impact of inpatient diabetic hypoglycemia

Endocrine Practice

Volumn 15, Issue 4, 2009, Pages 302-312

  Curkendall, Suellen M ^a   Natoli, Jaime L ^a   Alexander, Charles M ^b   Nathanson, Brian H ^c   Haidar, Tracy ^a   Dubois, Robert W ^a  

^a CERNER CORPORATION   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c OptiStatim LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYPERGLYCEMIC AGENT; LONG ACTING INSULIN;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; ECONOMIC ASPECT; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIA; INPATIENTS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 67649218644     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP08343.OR     Document Type: Article

References (38)

1. Currie CJ, Morgan CL, Poole CD, Sharplin P, Lammert M, McEwan P. Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr Med Res Opin. 2006;22:1523-1534.
2. Brackenridge A, Wallbank H, Lawrenson RA, Russell-Jones D. Emergency management of diabetes and hypoglycaemia. Emerg Med J. 2006;23:183-185.
3. Lundkvist J, Berne C, Bolinder B, J̈nsso L. The economic and quality of life impact of hypoglycemia. Eur J Health Econ. 2005;6:197-202.
4. Rhoads GG, Orsini LS, Crown W, Wang S, Getahun D, Zhang Q. Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes. J Occup Environ Med. 2005;47:447-452.
5. Leese GP, Wang J, Broomhall J, et al; DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26:1176-1180.
6. Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med. 2008;25:245-254.
7. Heaton A, Martin S, Brelje T. The economic effect of hypoglycemia in a health plan. Manag Care Interface. 2003;16:23-27.
8. J̈nsson L, Bolinder B, Lundkvist J. Cost of hypoglycemia in patients with type 2 diabetes in Sweden. Value Health. 2006;9:193-198.
9. Kagansky N, Levy S, Rimon E, et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med. 2003;163:1825-1829.
10. Stagnaro-Green A, Barton MK, Linekin PL, Corkery E, deBeer K, Roman SH. Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. Mt Sinai J Med. 1995;62:422-426.
11. Mellbin LG, Malmberg K, Waldenstr̈m A, Wedel H, Rydén L; DIGAMI 2 investigators. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial. Heart. 2009;95:721-727.
12. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005;26:1255-1261.
13. US Department of Labor: Bureau of Labor Statistics. Archived Consumer Price Index Detailed Report Information. Available at: http://www.bls.gov/cpi/ cpi-dr.htm#2006. Last updated 2007. Accessed August 21, 2007.
14. Kurth T, Walker AM, Glynn RJ, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol. 2006;163: 262-270.
15. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf. 2004;13:841-853.
16. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26:734-753.
17. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
18. Austin PC, Tu JV. Bootstrap methods for developing predictive models. Am Stat. 2004;58:131-137.
19. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
20. Raftery AE. Bayesian model selection in social research. In: Marsden PV, ed. Sociological Methodology. Vol 25. Oxford, England: Basil Blackwell, 1995: 111-163.
21. White H. Asymptotic Theory for Econometricians. New York, NY: Academic Press, 1984.
22. Efron B. Nonparametric estimates of standard error: The jackknife, the bootstrap and other methods. Biometrika. 2007;68:589-599.
23. Davison AC, Hinkley DV. Bootstrap Methods and Their Applications. Cambridge, UK: Cambridge University Press, 1997.
24. Clement S, Braithwaite SS, Magee MF, et al; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals [errata in Diabetes Care. 2004;27:856 and Diabetes Care. 2004;27:1255]. Diabetes Care. 2004;27:553-591.
25. Coutaz M, Nicod M, Chassot M, Morisod J. Monitoring hypoglycemia in elderly diabetic patients: a prospective study [article in French]. Rev Med Suisse. 2007;3:1071-1076.
26. Garber AJ, Moghissi ES, Bransome ED Jr, et al; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10:77-82.
27. Moghissi E. Hospital management of diabetes: beyond the sliding scale. Cleve Clin J Med. 2004;71:801-808.
28. Allicar MP, Mégas F, Houzard S, Baroux A, Le Thai F, Augendre-Ferrante B. Frequency and costs of hospital stays for hypoglycemia in France in 1995 [article in French]. Presse Med. 2000;29:657-661.
29. Ahmann A. Reduction of hospital costs and length of stay by good control of blood glucose levels. Endocr Pract. 2004;10(Suppl 2):53-56.
30. Duckworth WC. ACCORD Trial-Study Results. Presented at: the Symposium of the 68th Scientific Sessions of the American Diabetes Association; June 10, 2008; San Francisco, CA.
31. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559.
32. Chetty VT, Almulla A, Odueyungbo A, Thabane L. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. Diabetes Res Clin Pract. 2008;81:79-87.
33. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902-1912.
34. Laitinen T, Lyyra-Laitinen T, Huopio H, et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol. 2008;13:97-105.
35. Koivikko ML, Karsikas M, Salmela PI, et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia. 2008;51:426-435.
36. Abraira C, Duckworth W, McCarren M, et al; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. J Diabetes Complications. 2003;17:314-322.
37. Abraira C, Moritz TE, Reaven P, Duckworth WC, Fonseca V. Glycemic Control and Cardiovascular Outcomes-The VA Diabetes Trial. Presented at: the Symposium of the 68th Scientific Sessions of the American Diabetes Association; June 8, 2008; San Francisco, CA.
38. ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.